Medadvisor Ltd (MDR) - Cash Flow Conversion Efficiency

Latest as of June 2025: 5.093x

Based on the latest financial reports, Medadvisor Ltd (MDR) has a cash flow conversion efficiency ratio of 5.093x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-8.24 Million ≈ $-5.83 Million USD) by net assets (AU$-1.62 Million ≈ $-1.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Medadvisor Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Medadvisor Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read MDR total debt and obligations for a breakdown of total debt and financial obligations.

Medadvisor Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medadvisor Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Check-Cap Ltd
F:7CC
2.441x
Saxlund Group AB
ST:SAXG
-0.028x
Conduit Pharmaceuticals Inc.
NASDAQ:CDT
0.194x
Euroland Corporate SA
PA:MLERO
N/A
IZOTROPIC CORP.
F:1R3
0.029x
Plasto-Cargal Group Ltd
TA:PLCR
0.066x
Meta Epsi Tbk PT
JK:MTPS
0.244x
Primeserv Group Ltd
JSE:PMV
0.041x

Annual Cash Flow Conversion Efficiency for Medadvisor Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Medadvisor Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see MDR company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-1.62 Million
≈ $-1.14 Million
AU$-14.37 Million
≈ $-10.16 Million
8.880x +8729.14%
2024-06-30 AU$51.58 Million
≈ $36.50 Million
AU$5.19 Million
≈ $3.67 Million
0.101x +435.19%
2023-06-30 AU$48.46 Million
≈ $34.29 Million
AU$-1.45 Million
≈ $-1.03 Million
-0.030x -338.61%
2022-06-30 AU$34.55 Million
≈ $24.44 Million
AU$-236.32K
≈ $-167.21K
-0.007x +97.34%
2021-06-30 AU$48.85 Million
≈ $34.56 Million
AU$-12.54 Million
≈ $-8.88 Million
-0.257x +49.65%
2020-06-30 AU$17.02 Million
≈ $12.04 Million
AU$-8.68 Million
≈ $-6.14 Million
-0.510x +36.52%
2019-06-30 AU$8.64 Million
≈ $6.12 Million
AU$-6.95 Million
≈ $-4.91 Million
-0.803x -272.90%
2018-06-30 AU$15.17 Million
≈ $10.73 Million
AU$-3.27 Million
≈ $-2.31 Million
-0.215x +16.19%
2017-06-30 AU$9.35 Million
≈ $6.62 Million
AU$-2.40 Million
≈ $-1.70 Million
-0.257x +75.12%
2016-06-30 AU$2.46 Million
≈ $1.74 Million
AU$-2.55 Million
≈ $-1.80 Million
-1.033x -123.13%
2015-06-30 AU$-106.88K
≈ $-75.63K
AU$-477.40K
≈ $-337.79K
4.467x +155.67%
2014-06-30 AU$310.98K
≈ $220.04K
AU$-2.50 Million
≈ $-1.77 Million
-8.024x -2576.88%
2013-06-30 AU$11.11 Million
≈ $7.86 Million
AU$-3.33 Million
≈ $-2.36 Million
-0.300x -44.27%
2012-06-30 AU$2.78 Million
≈ $1.97 Million
AU$-577.73K
≈ $-408.78K
-0.208x -5068.77%
2011-06-30 AU$3.14 Million
≈ $2.22 Million
AU$-12.62K
≈ $-8.93K
-0.004x --

About Medadvisor Ltd

AU:MDR Australia Health Information Services
Market Cap
$9.91 Million
AU$14.00 Million AUD
Market Cap Rank
#26900 Global
#1342 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.13
All Time High
AU$0.66
About

Adheris Health Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, the United States, and the United Kingdom. The company offers THRiV, an omni-channel platform which provides pharmacy-driven patient and pharmacist engagement solutions to improve medication management. The company was formerly known as MedAdvisor Limited and changed its anm… Read more